Brain Monitoring Devices Global Market-Forecast to 2023

Publishing Date : April, 2017
Report Code : HCMD0144
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Brain monitoring is a technology including the application of different devices to image or monitor the structure, function or pharmacology of the brain. Brain monitoring techniques are segmented into structural imaging and functional imaging where structural imaging includes the diagnosis of the nervous system in a larger scale for the disorders like tumor, injury by techniques like CT and MRI. Functional imaging includes the diagnosis in a finer scale for the Alzheimer’s disease and other psychiatric behavioural disorders by devices like EEG, MEG, ICP, TCD, oximeters and PET devices. The functional imaging data provides images of the brain as patients complete tasks, such as solving math problems, reading, or responding to stimuli such as auditory sounds or flashing lights. Current brain monitoring techniques provides both form and functions of the brain like brain anatomy, integrity of the brain structures, brain’s chemistry, physiology and electrical and metabolic activity. EEG records the electrical activity associated with the neuronal depolarization and MEG records the magnetic field produced by these electrical activity.

Improvements in technology, methodology and interpretation continue to come up at an enhancing rate in the field of brain monitoring devices market. From the past decade there are tremendous progressive refinements in brain monitoring devices in terms of portability, efficiency, cost and invasive & non-invasive nature. The transitions includes from conventional, heavy room occupying EEG monitoring machines to modern portable, wireless, mobile machines with advanced computational power . The recent advancements in these devices includes a new brain monitoring device by a research team from the Perelman School of Medicine at the University of Pennsylvania that is implanted with in the brain and naturally melts away over time hence avoiding the surgical removal. This implanted device continuously sends data regarding the brain health of the patients. Electrophysiological signals were tracked for 30 days by devices located on the surface of the brain cortex and the area between the skull and scalp.

Over the years, the speed, efficacy, cost-effectiveness of brain monitoring devices have spread its usage across all clinical applications, from  epilepsy, stroke, dementia, TBI and other applications to surgeries and anaesthesia and so on.

The brain monitoring devices global market is expected to grow at mid single digit CAGR to reach $10,011.5 million by 2023. Brain monitoring devices market is mainly classified into products, application and end-users.

The product classification consists of electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, transcranial Doppler sonography (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices and accessories. The electroencephalography devices market is further segmented into by product type which includes 8-channel, 21-channel, 25-channel, 32-channel, 40-channel and multi-channel and by modality includes standalone/fixed EEG devices and portable EEG devices. The magnetic resonance imaging is divided based upon technology into low and middle field MRI, high field MRI and very high field MRI. Finally computed tomography devices is further classified into low slice CT, medium slice CT and high slice CT depending on the technology.

The global brain monitoring devices market by application is segmented into neurodegenerative disorders, brain tumor, sleep disorders, psychiatric behavioural disorders and other applications. The neurodegenerative disorders is sub segmented into epilepsy, Parkinson’s disease, Huntington’s disease, stroke, traumatic brain injury (TBI) and dementia whereas sleep disorders is sub classified into sleep apnea, insomnia, hypersomnia and sleep movement disorders. Psychiatric behavioural disorders are sub divided into autism, schizophrenia, dyslexia, bipolar disorders and depression. Other application is sub segmented into surgery, headache disorders, anesthesia and hydrocephalus.

The end-users of brain monitoring devices market are hospitals, home care, ambulatory surgical centers and clinics, diagnostic centers and other end users. 

Among the devices market, the sleep monitoring devices segment dominated the market by occupying a largest share and cerebral oximeters market is the fastest growing segment from 2016 to 2023. Likewise, under applications section neurodegenerative disorders segment holds the largest share and also the fastest growing segment from 2016 to 2023. By end-users, hospital is the largest segment and is the fastest segment growing segment from 2016 to 2023. Geographical wise, North America is the largest market share followed by Europe, Asia-Pacific and Rest of the World. The Asia region is the fastest growing region from 2016 to 2023 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the brain monitoring devices market. Growth in the Asian market is attributed to rising prevalence of neurological diseases, government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The brain monitoring devices global market is expected to grow at mid single digit CAGR from 2016 to 2023. The factors driving the growth of this market are growing incidence and prevalence of neurological disorders, rising awareness about neurodegenerative disorders, technological advancements/innovations offering wider scope of application for brain monitoring devices and growing healthcare spending.

While increasing focus on minimally invasive brain monitoring procedure and extended application of devices in clinical trials are some of the opportunities that are propelling the growth of the market.  However shortage of trained professionals, high cost of complex devices, unfavourable reimbursement policies, stringent regulatory guidelines and competition from local players in emerging markets are hampering the growth of the market.

The brain monitoring devices global market is a fragmented market whereas each product devices is highly consolidated and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the brain monitoring devices market are Advanced Brain Monitoring (U.S.), Cadwell laboratories (U.S.), CAS Medicals Inc.(U.S), Compumedics Limited (Australia), Electrical Geodesics Incorporated (U.S.), Elekta AB (Sweden), GE Healthcare (U.S.), Integra Lifesciences (U.S.), Koninklijke Philips N.V. (Netherland), Masimo corporation (U.S.), Medtronic (Ireland), Natus Medical Inc.(U.S.), Nihon Kohden Corporation (Japan) and Siemens Healthineers (Germany).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World (RoW)

  • 1     EXCEUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKE AWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET CRACKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.5     PRIMARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     GROWING INCIDENCE AND PREVALENCE OF NEUROLOGICAL DISORDERS
        • 3.3.1.2     RISING AWARENESS ABOUT NEURODEGENERATIVE DISORDERS
        • 3.3.1.3     GROWING HEALTHCARE SPENDING
        • 3.3.1.4     TECHNOLOGICAL ADVANCEMENTS/INNOVATIONS OFFERING WIDER SCOPE OF APPLICATIONS FOR BRAIN MONITORING
        • 3.3.1.5     INCREASING FOCUS ON MINIMALLY INVASIVE BRAIN ACTIVITY MONITORING PROCEDURES
        • 3.3.1.6     EXTENDED APPLICATION OF DEVICES IN CLINICAL TRIALS
      • 3.3.2     RESTRAINTS & THREATS
        • 3.3.2.1     HIGH COST OF COMPLEX DEVICES
        • 3.3.2.2     LACK OF SKILLED NEUROLOGISTS
        • 3.3.2.3     STRINGENT REGULATIONS AND LEGISLATIONS GUIDING THE BRAIN MONITORING DEVICE MANUFACTURERS
        • 3.3.2.4     UNFAVORABLE REIMBURSEMENT POLICIES
    • 3.4     PORTER’S FIVE FORCE ANALYSIS
      • 3.4.1     THREAT OF NEW ENTRANTS
      • 3.4.2     THREAT OF SUBSTITUTES
      • 3.4.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.4.4     BARGAINING POWER OF SUPPLIERS
      • 3.4.5     BARGAINING POWER OF BUYERS
    • 3.5     REGULATORY GUIDELINES
      • 3.5.1     UNITED STATES
      • 3.5.2     EUROPE
      • 3.5.3     JAPAN
      • 3.5.4     INDIA
      • 3.5.5     CHINA
    • 3.6     REIMBURSEMENT SCENARIO
      • 3.6.1     REIMBURSEMENT TABLE
    • 3.7     PATENT TRENDS
    • 3.8     SUPPLY CHAIN ANALYSIS
    • 3.9     BRAIN MONITORING DEVICES NUMBER OF UNITS
    • 3.10     BRAIN MONITORING DEVICES UNDER CLINICAL TRIAL
    • 3.11     RECENT TECHNIQUES BASED-ON APPLICATION
    • 3.12     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
    • 3.13     INDIVIDUAL BRAIN MONITORING DEVICES MARKET SHARE ANALYSIS BY MAJOR PLAYERS
    • 3.14     TECHNOLOGICAL ADVANCEMENT
      • 3.14.1     DISSOLVABLE BRAIN IMPLANTS
      • 3.14.2     DIFFUSED OPTICAL TOMOGRAPHY (DOT)
      • 3.14.3     EAR ELECTROENCEPHALOGRAPHY (EAR-EEG)
      • 3.14.4     PORTABLE EEG DEVICES
      • 3.14.5     BRAIN TISSUE OXYGEN TENSION MONITORS
      • 3.14.6     WIRELESS HELMET
  • 4     BRAIN MONITORING DEVICES GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     ELECTROENCEPHALOGRAPHY (EEG) DEVICES
      • 4.2.1     BY PRODUCT TYPE
        • 4.2.1.1     8-CHANNEL EEG
        • 4.2.1.2     21-CHANNEL EEG
        • 4.2.1.3     25-CHANNEL EEG
        • 4.2.1.4     32-CHANNEL EEG
        • 4.2.1.5     40-CHANNEL EEG
        • 4.2.1.6     MULTI-CHANNEL EEG
      • 4.2.2     BY MODALITY
        • 4.2.2.1     STANDALONE OR FIXED ELECTROENCEPHALOGRAPHY
        • 4.2.2.2     PORTABLE ELECTROENCEPHALOGRAPHY
    • 4.3     MAGNETOENCEPHALOGRAPHY (MEG) DEVICES
    • 4.4     INTRACRANIAL PRESSURE (ICP) MONITORS
    • 4.5     TRANSCRANIAL DOPPLER SONOGRAPHY DEVICES
    • 4.6     CEREBRAL OXIMETERS
    • 4.7     MAGNETIC RESONANCE IMAGING (MRI) DEVICES
      • 4.7.1     BY TECHNOLOGY
        • 4.7.1.1     LOW AND MIDDLE FIELD MRI
        • 4.7.1.2     HIGH FIELD MRI
        • 4.7.1.3     VERY HIGH FIELD MRI
    • 4.8     COMPUTERIZED TOMOGRAPHY (CT) DEVICES
      • 4.8.1     BY TECHNOLOGY
        • 4.8.1.1     LOW SLICE CT
        • 4.8.1.2     MEDIUM SLICE CT
        • 4.8.1.3     HIGH SLICE CT
    • 4.9     POSITRON EMISSION TOMOGRAPHY (PET) DEVICES
    • 4.1     SLEEP MONITORING DEVICES
    • 4.11     BY ACCESSORIES
  • 5     BRAIN MONITORING DEVICES GLOBAL MARKET, BY APPLICATIONS
    • 5.1     INTRODUCTION
    • 5.2     NEURODEGENERATIVE DISORDERS
      • 5.2.1     EPILEPSY
      • 5.2.2     PARKINSON’S DISEASE
      • 5.2.3     HUNTINGTON’S DISEASE
      • 5.2.4     STROKE
      • 5.2.5     TRAUMATIC BRAIN INJURY (TBI)
      • 5.2.6     DEMENTIA
    • 5.3     BRAIN TUMOR
    • 5.4     SLEEP DISORDERS
      • 5.4.1     INSOMNIA
      • 5.4.2     HYPERSOMNIA
      • 5.4.3     SLEEP APNEA
      • 5.4.4     SLEEP MOVEMENT DISORDERS
    • 5.5     PSYCHIATRIC BEHAVIORAL DISORDERS
      • 5.5.1     AUTISM
      • 5.5.2     SCHIZOPHRENIA
      • 5.5.3     DYSLEXIA
      • 5.5.4     DEPRESSION
      • 5.5.5     BIPOLAR DISORDERS
    • 5.6     OTHER APPLICATIONS
      • 5.6.1     SURGERY
      • 5.6.2     ANESTHESIA
      • 5.6.3     HYDROCEPHALUS
      • 5.6.4     HEADACHE DISORDERS
  • 6     BRAIN MONITORING DEVICES GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     HOME CARE
    • 6.4     AMBULATORY SURGICAL CENTERS AND CLINICS
    • 6.5     DIAGNOSTIC LABORATORIES
    • 6.6     OTHER END-USERS
  • 7     REGIONAL ANALYSIS
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     UNITED STATES
      • 7.2.2     OTHERS
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     FRANCE
      • 7.3.3     UNITED KINGDOM
      • 7.3.4     OTHERS
    • 7.4     ASIA-PACIFIC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     OTHERS
    • 7.5     REST OF THE WORLD
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST AND OTHERS
  • 8     COMPETITIVE LANDSCAPE
    • 8.1     INTRODUCTION
    • 8.2     NEW PRODUCT LAUNCHES
    • 8.3     AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES
    • 8.4     APPROVALS
    • 8.5     MERGERS & ACQUISITIONS
    • 8.6     OTHER DEVELOPMENTS
  • 9     MAJOR COMPANIES
    • 9.1     ADVANCED BRAIN MONITORING
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     CADWELL INDUSTRIES INC.
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     CAS MEDICAL SYSTEMS INC
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     COMPUMEDICS LIMITED
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     ELEKTA AB
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     ELECTRICAL GEODESICS, INC
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     GE HEALTHCARE
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     INTEGRA LIFE SCIENCES
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     KONINKLIJKE PHILIPS N.V.
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     MASIMO CORPORATION
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS
    • 9.11     MEDTRONIC, PLC
      • 9.11.1     OVERVIEW
      • 9.11.2     FINANCIALS
      • 9.11.3     PRODUCT PORTFOLIO
      • 9.11.4     KEY DEVELOPMENTS
      • 9.11.5     BUSINESS STRATEGY
      • 9.11.6     SWOT ANALYSIS
    • 9.12     NATUS MEDICAL INCORPORATED
      • 9.12.1     OVERVIEW
      • 9.12.2     FINANCIALS
      • 9.12.3     PRODUCT PORTFOLIO
      • 9.12.4     KEY DEVELOPMENTS
      • 9.12.5     BUSINESS STRATEGY
      • 9.12.6     SWOT ANALYSIS
    • 9.13     NIHON KOHDEN CORPORATION
      • 9.13.1     OVERVIEW
      • 9.13.2     FINANCIALS
      • 9.13.3     PRODUCT PORTFOLIO
      • 9.13.4     KEY DEVELOPMENTS
      • 9.13.5     BUSINESS STRATEGY
      • 9.13.6     SWOT ANALYSIS
    • 9.14     SIEMENS AG
      • 9.14.1     OVERVIEW
      • 9.14.2     FINANCIALS
      • 9.14.3     PRODUCT PORTFOLIO
      • 9.14.4     KEY DEVELOPMENTS
      • 9.14.5     BUSINESS STRATEGY
      • 9.14.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 2     BRAIN MONOTORING DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 3     ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2015-2023) ($MN)
      • TABLE 4     ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY MODALITY, (2015-2023) ($MN)
      • TABLE 5     MAGNETIC RESONANCE IMAGING DEVICES GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 6     COMPUTED TOMOGRAPHY DEVICES GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 7     BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 8     NEURODEGENERATIVE DISORDERS GLOBAL MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 9     SLEEP DISORDERS GLOBAL MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 10     PSYCHIATRIC BEHAVIORAL DISORDERS GLOBAL MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 11     OTHER BRAIN MONITORING DEVICES APPLICATIONS GLOBAL MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 12     BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 13     ELECTROENCEPHALOGRAPHY MONITORING DEVICES NUMBER OF UNITS, BY REGION, (2015-2023)
      • TABLE 14     MAGNETOENCEPHALOGRAPHY MONITORING DEVICES NUMBER OF UNITS, BY REGION, (2015-2023)
      • TABLE 15     TRANSCRANIAL DOPPLER SONOGRAPHY DEVICES NUMBER OF UNITS, BY REGION, (2015-2023)
      • TABLE 16     CEREBRAL OXIMETERS NUMBER OF UNITS, BY REGION, (2015-2023)
      • TABLE 17     BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 18     ELECTROENCEPHALOGRAPHY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 19     ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2015-2023) ($MN)
      • TABLE 20     8-CHANNEL ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 21     21-CHANNEL ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 22     25-CHANNEL ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 23     32-CHANNEL ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 24     40-CHANNEL ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 25     MULTI-CHANNEL ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 26     ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY MODALITY, (2015-2023) ($MN)
      • TABLE 27     STANDALONE OR FIXED ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 28     PORTABLE ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 29     MAGENTOENCEPHALOGRAPHY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 30     INTRACRANIAL PRESSURE MONITORS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 31     TRANCRANIAL DOPPLER SONOGRAPHY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 32     CEREBRAL OXIMETER DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 33     MAGNETIC RESONANCE IMAGING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 34     MAGNETIC RESONANCE IMAGING DEVICES GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 35     LOW AND MIDDLE FIELD MAGNETIC RESONANCE IMAGING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 36     HIGH FIELD MAGNETIC RESONANCE IMAGING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 37     VERY HIGH FIELD MAGNETIC RESONANCE IMAGING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 38     COMPUTED TOMOGRAPHY MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 39     COMPUTED TOMOGRAPHY DEVICES GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 40     LOW SLICE COMPUTED TOMOGRAPHY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 41     MEDIUM SLICE COMPUTED TOMOGRAPHY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 42     HIGH SLICE COMPUTED TOMOGRAPHY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 43     POSITRON EMISSION TOMOGRAPHY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 44     SLEEP MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 45     BRAIN MONITORING DEVICE ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 46     BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 47     NEURODEGENERATIVE DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 48     NEURODEGENERATIVE DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 49     EPILEPSY DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 50     PARKINSON’S DISEASE APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 51     HUNTINGTON’S DISEASE APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 52     STROKE DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 53     TRAUMATIC BRAIN INJURY DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 54     DEMENTIA DISORDER APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 55     BRAIN TUMOR APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 56     SLEEP DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 57     SLEEP DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 58     INSOMNIA DISORDER APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 59     HYPERSOMNIA DISORDER APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 60     SLEEP APNEA DISORDER APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 61     SLEEP MOVEMENT DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 62     PSYCHIATRIC BEHAVIORAL DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 63     PSYCHIATRIC BEHAVIORAL DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 64     AUTISM DISORDER APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 65     SCHIZOPHRENIA DISORDER APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 66     DYSLEXIA DISORDER APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 67     DEPRESSION DISORDER APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 68     BIPOLAR DISORDER APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 69     BRAIN MONITORING DEVICES OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 70     BRAIN MONITORING DEVICES OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 71     SURGERY APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 72     ANESTHESIA APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 73     HYDROCEPHALUS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 74     HEADACHE DISORDERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 75     BRAIN MONITORING DEVICES END-USERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 76     HOSPITAL END-USERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 77     HOME CARE SETTINGS END-USERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 78     AMBULATORY SURGICAL CENTRES END-USERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 79     DIAGNOSTIC LABORATORIES END-USERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 80     BRAIN MONITORING DEVICES OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 81     BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 82     NORTH AMERICAN BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 83     NORTH AMERICAN ELECTROENCEPHALOGRAPHY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2015-2023) ($MN)
      • TABLE 84     NORTH AMERICAN ELECTROENCEPHALOGRAPHY DEVICES MARKET REVENUE, BY MODALITY, (2015-2023) ($MN)
      • TABLE 85     NORTH AMERICAN MAGNETIC RESONANCE IMAGING DEVICES MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 86     NORTH AMERICAN COMPUTED TOMOGRAPHY DEVICES MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 87     NORTH AMERICAN BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 88     NORTH AMERICAN NEURODEGENERATIVE DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 89     NORTH AMERICAN SLEEP DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 90     NORTH AMERICAN PSYCHAITRIC BEHAVIORAL DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 91     NORTH AMERICAN BRAIN MONITORING DEVICES OTHER APPLICATIONS MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 92     NORTH AMERICAN BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 93     EUROPEAN BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 94     EUROPEAN ELECTROENCEPHALOGRAPHY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2015-2023) ($MN)
      • TABLE 95     EUROPEAN ELECTROENCEPHALOGRAPHY DEVICES MARKET REVENUE, BY MODALITY, (2015-2023) ($MN)
      • TABLE 96     EUROPEAN MAGNETIC RESONANCE IMAGING DEVICES MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 97     EUROPEAN COMPUTED TOMOGRAPHY DEVICES MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 98     EUROPEAN BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 99     EUROPEAN NEURODEGENERATIVE DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 100     EUROPEAN SLEEP DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 101     EUROPEAN PSYCHAITRIC BEHAVIORAL DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 102     EUROPEAN BRAIN MONITORING DEVICES OTHER APPLICATIONS MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 103     EUROPEAN BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 104     ASIA-PACIFIC BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 105     ASIA-PACIFIC ELECTROENCEPHALOGRAPHY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2015-2023) ($MN)
      • TABLE 106     ASIA-PACIFIC ELECTROENCEPHALOGRAPHY DEVICES MARKET REVENUE, BY MODALITY, (2015-2023) ($MN)
      • TABLE 107     ASIA-PACIFIC MAGNETIC RESONANCE IMAGING DEVICES MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 108     ASIA-PACIFIC COMPUTED TOMOGRAPHY DEVICES MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 109     ASIA-PACIFIC BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 110     ASIA-PACIFIC NEURODEGENERATIVE DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 111     ASIA-PACIFIC SLEEP DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 112     ASIA-PACIFIC PSYCHAITRIC BEHAVIORAL DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 113     ASIA-PACIFIC BRAIN MONITORING DEVICES OTHER APPLICATIONS MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 114     ASIA-PACIFIC BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 115     REST OF THE WORLD BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 116     REST OF THE WORLD ELECTROENCEPHALOGRAPHY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2015-2023) ($MN)
      • TABLE 117     REST OF THE WORLD ELECTROENCEPHALOGRAPHY DEVICES MARKET REVENUE, BY MODALITY, (2015-2023) ($MN)
      • TABLE 118     REST OF THE WORLD MAGNETIC RESONANCE IMAGING DEVICES MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 119     REST OF THE WORLD COMPUTED TOMOGRAPHY DEVICES MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 120     REST OF THE WORLD BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 121     REST OF THE WORLD NEURODEGENERATIVE DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 122     REST OF THE WORLD SLEEP DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 123     REST OF THE WORLD PSYCHAITRIC BEHAVIORAL DISORDERS APPLICATION MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 124     REST OF THE WORLD BRAIN MONITORING DEVICES OTHER APPLICATIONS MARKET REVENUE, BY DISEASE TYPE, (2015-2023) ($MN)
      • TABLE 125     REST OF THE WORLD BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 126     NEW PRODUCT LAUNCHES (2014-2016)
      • TABLE 127     AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES (2014-2016)
      • TABLE 128     APPROVALS (2014-2016)
      • TABLE 129     MERGERS & ACQUISITIONS (2014-2016)
      • TABLE 130     OTHER DEVELOPMENTS (2014-2016)
      • TABLE 131     CAS MEDICAL SYSTEMS INC. : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 132     CAS MEDICAL SYSTEMS INC. : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 133     CAS MEDICAL SYSTEMS INC. : TOTAL REVENUE, BY TISSUE OXIMETRY MONITORING (2014-2016) ($MN)
      • TABLE 134     CAS MEDICAL SYSTEMS INC. : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 135     COMPUMEDICS LIMITED : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 136     COMPUMEDICS LIMITED : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 137     ELEKTA AB : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 138     ELEKTA AB : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 139     ELEKTA AB : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 140     ELECTRICAL GEODESICS INC,: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 141     ELECTRICAL GEODESICS INC,: TOTAL REVENUE, BY SEGMENT, (2014-2016) ($MN)
      • TABLE 142     ELECTRICAL GEODESICS INC, : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 143     GE HEALTHCARE : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 144     GENERAL ELECTRIC COMPANY : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 145     GENERAL ELECTRIC COMPANY : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 146     INTEGRA LIFE SCIENCES : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 147     INTEGRA LIFE SCIENCES : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 148     INTEGRA LIFE SCIENCES : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 149     PHILIPS N.V. : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 150     PHILIPS N.V. : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 151     PHILIPS N.V. : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 152     MASIMO CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 153     MASIMO CORPORATION : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 154     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 155     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 156     MEDTRONIC, PLC: TOTAL REVENUE BY SUB-SEGMENTS MINIMALLY INVASIVE THERAPIES GROUP (2014-2016) ($MN)
      • TABLE 157     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 158     NATUS MEDICAL INCORORATED : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 159     NATUS MEDICAL INCORPORATED : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 160     NATUS MEDICAL INCORPORATED : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 161     NIHON KOHDEN CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 162     NIHON KOHDEN CORPORATION : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 163     NIHON KOHDEN CORPORATION : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 164     SIEMENS AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 165     SIEMENS AG: TOTAL REVENUE, BY SEGMENT, (2014-2016) ($MN)
      • TABLE 166     SIEMENS AG : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     BRAIN MONITORING DEVICES GLOBAL MARKET SHARE AND REVENUE, BY REGION (2015-2023)
      • FIGURE 2     BRAIN MONITORING DEVICES GLOBAL MARKET: RESEARCH APPROACH
      • FIGURE 3     BRAIN MONITORING DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     BRAIN MONITORING DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     BRAIN MONITORING DEVICES GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
      • FIGURE 6     BRAIN MONITORING DEVICES GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     BRAIN MONITORING DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     BRAIN MONITORING DEVICES GLOBAL MARKET: PCT PATENT FILING BY MAJOR PLAYERS (2011-2016)
      • FIGURE 10     BRAIN MONITORING DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
      • FIGURE 11     ELECTROENCEPHALOGRAPHY MONITORING DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
      • FIGURE 12     MAGNETOENCEPHALOGRAPHY MONITORING DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
      • FIGURE 13     CEREBRAL OXIMETERS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
      • FIGURE 14     TRANSCRANIAL DOPPLER SONOGRAPHY MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
      • FIGURE 15     INTRACRANIAL PRESSURE MONITORS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
      • FIGURE 16     BRAIN MONITORING DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2016 V/S 2023)
      • FIGURE 17     ELECTROENCEPHALOGRAPHY GLOBAL MARKET SHARE, BY PRODUCT TYPE (2016 V/S 2023)
      • FIGURE 18     ELECTROENCEPHALOGRAPHY GLOBAL MARKET SHARE, BY MODALITY (2016 V/S 2023)
      • FIGURE 19     MAGNETIC RESONANCE IMAGING GLOBAL MARKET SHARE, BY TECHNOLOGY (2016 V/S 2023) (%)
      • FIGURE 20     COMPUTED TOMOGRAPHY GLOBAL MARKET SHARE, BY TECHNOLOGY (2016 V/S 2023) (%)
      • FIGURE 21     BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS (2016) (%)
      • FIGURE 22     BRAIN MONITORING DEVICES APPLICATION GLOBAL MARKET REVENUE, NEURODEGENERATIVE DISORDERS TYPE MARKET SHARE (2016) (%)
      • FIGURE 23     BRAIN MONITORING DEVICES APPLICATION GLOBAL MARKET REVENUE, SLEEP DISORDERS TYPE MARKET SHARE (2016) (%)
      • FIGURE 24     BRAIN MONITORING DEVICES APPLICATION GLOBAL MARKET REVENUE, PSYCHIATRIC BEHAVIORAL DISORDERS TYPE MARKET SHARE (2016) (%)
      • FIGURE 25     BRAIN MONITORING DEVICES APPLICATIONS GLOBAL MARKET SHARE REVENUE, OTHER DISORDERS TYPE (2016) (%)
      • FIGURE 26     BRAIN MONITORING DEVICES GLOBAL MARKET SHARE, BY END-USERS (2016 V/S 2023)
      • FIGURE 27     BRAIN MONITORING DEVICES GLOBAL MARKET SHARE AND REVENUE, BY REGION (2015-2023) ($MN) CAGR (%)
      • FIGURE 28     NORTH AMERICAN BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 29     NORTH AMERICAN BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 30     UNITED STATES BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 31     UNITED STATES BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 32     OTHER NORTH AMERICAN REGIONS BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 33     OTHER NORTH AMERICAN REGIONS BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 34     EUROPEAN BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 35     EUROPEAN BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 36     GERMANY BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 37     GERMANY BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 38     FRANCE BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 39     FRANCE BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 40     UNITED KINGDOM BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 41     UNITED KINGDOM BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 42     OTHER EUROPEAN REGIONS BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 43     OTHER EUROPEAN REGIONS BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 44     ASIA PACIFIC BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 45     ASIA-PACIFIC BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 46     JAPAN BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 47     JAPAN BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 48     CHINA BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 49     CHINA BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 50     INDIA BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 51     INDIA BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 52     OTHER ASIA PACIFIC REGIONS BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 53     OTHER ASIA-PACIFIC REGIONS BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 54     REST OF THE WORLD BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 55     REST OF THE WORLD BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 56     BRAZIL BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 57     BRAZIL BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 58     REST OF LATIN AMERICA BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 59     REST OF LATIN AMERICA BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 60     MIDDLE EAST AND OTHERS BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2016 V/S 2023) (%)
      • FIGURE 61     MIDDLE EAST AND OTHERS BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS AND END-USERS (2016 V/S 2023) ($MN)
      • FIGURE 62     KEY GROWTH STRATEGIES, (2014 – 2016)
      • FIGURE 63     SWOT: ADVANCED BRAIN MONITORING
      • FIGURE 64     SWOT: CADWELL LABORATORIES INC
      • FIGURE 65     SWOT: CAS MEDICAL SYSTEMS INC,
      • FIGURE 66     SWOT: COMPUMEDICS LIMITED
      • FIGURE 67     SWOT: ELEKTA AB
      • FIGURE 68     SWOT: ELECTRICAL GEODESICS INC.
      • FIGURE 69     SWOT: GE HEALTHCARE
      • FIGURE 70     SWOT: INTEGRA LIFESCIENCES
      • FIGURE 71     SWOT: PHILIPS N.V.
      • FIGURE 72     SWOT: MASIMO CORPORATION
      • FIGURE 73     SWOT: MEDTRONIC PLC
      • FIGURE 74     SWOT: NATUS MEDICAL INCORPORATED
      • FIGURE 75     SWOT: NIHON KOHDEN
      • FIGURE 76     SWOT: SIEMENS AG

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     AD INSTRUMENTS
      • 2     ADTECH MEDICAL INSTRUMENT CORPORATION
      • 3     ADVANCED BRAIN MONITORING INC
      • 4     ALLTECH MEDICAL SYSTEMS
      • 5     ANT NEURO
      • 6     ATYS MEDICAL
      • 7     AVERTUS INC
      • 8     AVONIX IMAGING
      • 9     B.M. TECH WORLDWIDE CO. LTD
      • 10     BEDDIT
      • 11     BIOPAC SYSTEMS INC
      • 12     BRAIN PRODUCTS GMBH
      • 13     BRAINSCOPE INC
      • 14     BRAINTRONICS B.V.
      • 15     CADWELL LABORATORIES
      • 16     CAS MEDICALS INC
      • 17     CEREBROTECH MEDICAL SYSTEMS
      • 18     CLEVEMED MEDICAL DEVICES INC
      • 19     CODMAN & SHURTLEFF
      • 20     COGNIONICS INC
      • 21     COMPUMEDICS LIMITED
      • 22     CONTEXT VISION
      • 23     CTF MEG INTERNATIONAL SERVICES
      • 24     DANTEC MEDICAL
      • 25     EB NEURO SPA
      • 26     ELECTRICAL GEODESICS INCORPORATED
      • 27     ELEKTA AB
      • 28     ELMINDA LIMITED
      • 29     EMOTIV INC
      • 30     ENTERTECH
      • 31     FISO TECHNOLOGIES INC
      • 32     FITBIT
      • 33     GAELTEC DEVICES LIMITED
      • 34     GE HEALTHCARE
      • 35     GLAXOSMITHKLINE
      • 36     HEADSENSE MEDICAL INC
      • 37     HEINEN + LÖWENSTEIN GMBH & CO. KG
      • 38     HELLO INC
      • 39     HITACHI LIMITED
      • 40     IMEC
      • 41     INFRASCAN INC
      • 42     INSIGHTEC
      • 43     INTEGRA LIFESCIENCES
      • 44     JAWBONE
      • 45     JOHNSON & JOHNSON
      • 46     KONINKLIJKE PHILIPS N.V.
      • 47     KOVEN TECHNOLOGY CANADA INC
      • 48     MAGNETICA
      • 49     MASIMO CORPORATION
      • 50     MEDTECH
      • 51     MEDTRONIC
      • 52     MICROMED SPA
      • 53     MISFIT
      • 54     MITSAR CO. LTD
      • 55     MOBERG RESEARCH
      • 56     MR SOLUTIONS
      • 57     NATUS MEDICAL INC
      • 58     NEMODEVICES AG
      • 59     NEURAL ANALYTICS INC
      • 60     NEUROCARE GROUP GMBH
      • 61     NEUROELECTRICS COMPANY
      • 62     NEUROPACE INC
      • 63     NEUROSKY
      • 64     NEUROSTYLE
      • 65     NEUROVIGIL
      • 66     NEUROWAVE SYSTEMS INC
      • 67     NEUSOFT MEDICAL SYSTEMS CO. LTD
      • 68     NIHON KOHDEN CORPORATION
      • 69     NONIN MEDICAL INC
      • 70     NOX MEDICAL
      • 71     ORNIM INC
      • 72     ORSAN MEDICAL TECHNOLOGIES LTD
      • 73     RAUMEDIC AG
      • 74     RECORDERS & MEDICARE SYSTEMS PVT LTD
      • 75     RESMED
      • 76     RHYTHM
      • 77     RICOH
      • 78     RIMED LIMITED
      • 79     RHYTHM
      • 80     SHENZHEN DELICA MEDICAL EQUIPMENT CO. LTD
      • 81     SIEMENS HEALTHINEERS
      • 82     SOMNOMEDICS GMBH
      • 83     SOPHYRA
      • 84     SPENCER TECHNOLOGIES
      • 85     SPIEGELBERG GMBH
      • 86     SYNTHETICMR
      • 87     THIRD EYE DIAGNOSTIC INC
      • 88     TOSHIBA
      • 89     TRISTAN TECHNOLOGIES INC
      • 90     VARIAN MEDICAL SYSTEMS
      • 91     VITTAMED CORPORATION
      • 92     WEINMANN MEDICAL TECHNOLOGY
      • 93     WIDE MED TECHNOLOGIES LTD
      • 94     WITHINGS